Community-based dementia risk management and prevention program for Aboriginal Australians (DAMPAA): a randomised controlled trial study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 Sep 2024
Historique:
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Aboriginal and Torres Strait Islander peoples are the First Peoples of Australia. Up to 45% of dementia in these populations is due to potentially modifiable risk factors. The Dementia Prevention and Risk Management Program for Aboriginal Australians (DAMPAA) is an Aboriginal Health Practitioner led programme that aims to reduce cognitive decline and functional impairment in older Aboriginal people. Design: DAMPAA is a multisite, randomised controlled trial aiming to deliver and evaluate a culturally appropriate risk factor management programme. Community-dwelling Aboriginal people aged 45-90 years. Participants will be randomly assigned to either usual care (control) or to a group programme comprising exercise and health education yarning sessions and pharmacist-delivered medication reviews delivered over a 12-month period. Cognitive function (Kimberley Indigenous Cognitive Assessment (KICA)-Cog score), daily function (KICA-Activities of Daily Living (ADL) score) and quality of life (Good Spirit, Good Life and EQ-5D-5L scores). Process evaluation interviews, cardiovascular risk factors, falls and death. Process evaluation will be conducted with qualitative methods. Quantitative outcomes will be analysed with generalised linear mixed models. The study was approved by the Western Australian Aboriginal Health Ethics Committee and the University of Western Australia Human Research Ethics Committee. Study results will be published in peer-reviewed journals and presented at scientific meetings. We will also develop and disseminate a comprehensive DAMPAA toolkit for health services. The study's findings will guide future prevention strategies and outline a comprehensive process evaluation that may be useful in other Aboriginal health research to contextualise findings.

Identifiants

pubmed: 39277208
pii: bmjopen-2024-088281
doi: 10.1136/bmjopen-2024-088281
doi:

Types de publication

Journal Article Clinical Trial Protocol Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e088281

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Alex Lalovic (A)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia alex.lalovic@uwa.edu.au kate.smith@uwa.edu.au.

Glennette Dowden (G)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Lesley Markey (L)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Michael Bynder (M)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Lynette Yappo (L)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Kay L Cox (KL)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.
Western Australian Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia.

Irene Mateo-Arriero (I)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Leon Flicker (L)

Western Australian Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia.

Dawn Bessarab (D)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.

Sandra Thompson (S)

Western Australian Centre for Rural Health, The University of Western Australia, Geraldton, Western Australia, Australia.

Carmel Kickett (C)

Moorditj Koort Aboriginal Corporation, Perth, Western Australia, Australia.

Deborah Woods (D)

Geraldton Regional Aboriginal Medical Service, Geraldton, Western Australia, Australia.

Carmela F Pestell (CF)

School of Psychological Science, University of Western Australia, Perth, Western Australia, Australia.

Paula Edgill (P)

Derbarl Yerrigan Health Service Aboriginal Corporation, Perth, Western Australia, Australia.

Keith Hill (K)

Rehabilitation Ageing and Independent Living Research Centre, Monash University, Melbourne, Victoria, Australia.

Christopher Etherton-Beer (C)

Western Australian Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia.

Dina LoGiudice (D)

Department of Medicine - Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.

Osvaldo P Almeida (OP)

Institute for Health Research, The University of Notre Dame Australia, Perth, Western Australia, Australia.

Ivan Lin (I)

Western Australian Centre for Rural Health, The University of Western Australia, Geraldton, Western Australia, Australia.

Rachel Milte (R)

Health and Social Care Economics Group, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.

Julie Ratcliffe (J)

Health and Social Care Economics Group, Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.

Zoë Hyde (Z)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia.
Western Australian Centre for Health and Ageing, The University of Western Australia, Perth, Western Australia, Australia.

Kate Smith (K)

Centre for Aboriginal Medical and Dental Health, The University of Western Australia, Perth, Western Australia, Australia alex.lalovic@uwa.edu.au kate.smith@uwa.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH